Quality of Life in Oncology Resource Centre
29 Nov 2013
To optimize quality of life in oncology patients preventive measures to avoid occurrence of adverse effects of the disease and its treatment are required. Where prevention is not feasible, proper management to minimize both physical and psychological adverse effects is needed. By maximizing the patient’s quality of life patient resilience is enhanced, supporting acceptance, rehabilitation, compliance and generally easing the significant emotional burden of both patients and care givers. Therefore, supportive care designed to uphold the quality of life of patients and those directly involved by preventing and alleviating the symptoms and complications of cancer (treatment) is essential to allow maximal benefit of the treatment options at hand.
Elsevier has launched a Quality of Life in Oncology Resource Centre providing free full-text access to peer-reviewed original research and review articles on the quality of life during all disease stages of cancer – from diagnosis to post-diagnostic care, as well as interviews with leading experts, links to guidelines on Supportive and Palliative Care in Cancer, clinical and teaching cases and podcasts and News updates from oncology conferences.
The editor-in-chief of the resource centre is Dr. Matti S. Aapro (Multidisciplinary Institute of Oncology, Genolier, Switzerland). The resource centre is supported by an international Editorial board of experts: Dr Florian Scotté (France) Dr Carla Ripamonti (Italy), Dr Ricardo Caponero (Brazil), Dr Anton Snegovoy (Russia) and Dr Martin Chasen (USA).
The Quality of Life in Oncology resource centre is supported by an educational grant from Helsinn and the company does not have any influence on the content and all items are subject to independent peer and editorial review.
Elsevier
Related News
EORTC calls for a balanced and feasible European Health Data Space (EHDS)
8 Jul 2026
Professor Benjamin Besse becomes President of EORTC
26 Jun 2026
CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer
24 Jun 2026
EORTC welcomes EU Biotech Act and calls for refinements to enable patient-centred trials
24 Jun 2026
New study confirms a key quality of life tool can be used with adolescents with cancer
9 Jun 2026
“Changing practice, improving lives”: EORTC publishes its Annual Report 2025
8 Jun 2026
This Clinical Trials Day, EORTC announces the upcoming Summit for Clinical Cancer Research
20 May 2026
Long-term EORTC trial challenges assumptions about lymph node radiation therapy in breast cancer
17 May 2026
Multinational study provides new evidence for the value of response-adapted, personalised treatment in Hodgkin lymphoma
1 May 2026
EORTC’s presence at ESTRO 2026
30 Apr 2026
